Grove Biopharma scientific founder Nathan Gianneschi (L) and CEO Geoffrey Duyk

Ex­clu­sive: Chica­go start­up Grove Bio­phar­ma nabs $30M Se­ries A

A small North­west­ern Uni­ver­si­ty spin­out at­tempt­ing to de­vel­op a twist on bi­o­log­ics has pulled to­geth­er a $30 mil­lion Se­ries A.

The start­up, named Grove Bio­phar­ma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.